A detailed history of Boothbay Fund Management, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 283,616 shares of PYXS stock, worth $473,638. This represents 0.03% of its overall portfolio holdings.

Number of Shares
283,616
Previous 492,462 42.41%
Holding current value
$473,638
Previous $1.63 Million 36.2%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.83 - $3.94 $591,034 - $822,853
-208,846 Reduced 42.41%
283,616 $1.04 Million
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $999,697 - $3.25 Million
492,462 New
492,462 $2.1 Million

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $58.6M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.